Pelitex’s will facilitate the rapid development of liquid biopsy In-Vitro diagnostics (IVD) approaches by providing new magnetic nanoparticle platforms designed to strongly bind, separate, and release small extracellular vehicles. Advances in liquid biopsy sampling is being led by next generation sequencing, automation, and big-data machine learning, which allows for highly precise non-invasive screens of diseases, injuries, and cancers.